folic acid has been researched along with Pneumonia, Viral in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Couper, J; MacKenzie, K; Peña, AS; Shaw, G; Wiltshire, E | 1 |
| Ata, O; Inci, TG; Kocer, S; Mutlu, O; Sariyer, E; Turgut-Balik, D; Ugurel, E; Ugurel, OM | 1 |
| Bevilacqua, M; Chiarioni, G; Dalbeni, A; Mazzaferri, F; Normelli, I; Teani, I | 1 |
3 other study(ies) available for folic acid and Pneumonia, Viral
| Article | Year |
|---|---|
High dose folic acid is a potential treatment for pulmonary hypertension, including when associated with COVID-19 pneumonia.
Topics: Administration, Inhalation; Animals; Betacoronavirus; Coronavirus Infections; COVID-19; Endothelium, Vascular; Enzyme Activation; Folic Acid; Humans; Hypertension, Pulmonary; Hypoxia; Mice; Nitric Oxide; Nitric Oxide Synthase Type III; Pandemics; Pneumonia, Viral; SARS-CoV-2; Tachyphylaxis | 2020 |
Evaluation of the potency of FDA-approved drugs on wild type and mutant SARS-CoV-2 helicase (Nsp13).
Topics: Adenosine Monophosphate; Amino Acid Sequence; Betacoronavirus; Binding Sites; Computer Simulation; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Approval; Drug Repositioning; Enzyme Inhibitors; Folic Acid; Genome, Viral; Glucosides; Humans; Methyltransferases; Molecular Docking Simulation; Mutation; Pandemics; Pneumonia, Viral; RNA Helicases; SARS-CoV-2; Stilbenes; Vidarabine; Viral Nonstructural Proteins | 2020 |
Excessive vitamin B12 and poor outcome in COVID-19 pneumonia.
Topics: Aged; Aged, 80 and over; COVID-19; Female; Folic Acid; Humans; Intensive Care Units; Male; Middle Aged; Pneumonia, Viral; Prospective Studies; SARS-CoV-2; Vitamin B 12; Vitamin B 12 Deficiency | 2021 |